What this means
This study will compare blood proteins and markers of cell aging in cancer survivors and people who never had cancer. It does not yet show any results, so we cannot tell what it will find.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 5–50
- Where
- 1 site, including Ohio
The science
- Registered title
- Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors
- Trial ID
- NCT07114614 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Marker; Structural
- What is tested
- Specimen #1, Specimen #2
- Sponsor
- Case Comprehensive Cancer Center
- Ages
- 5 Years to 50 Years
- Dates
- First posted Aug 11, 2025 · updated Aug 26, 2026
Registry summary
The purpose of this research study is to investigate whether cancer survivors have higher levels of proteins called Fatty Acid Binding Proteins as well as 12 different markers of cellular senescence than people who have never had cancer. Investigators believe that these levels may be elevated in cancer survivors as a result of their cancer and the treatments they received and may put them at higher risk for chronic conditions such as high cholesterol, diabetes, high blood pressure, and obesity. This study will also compare the levels of these proteins and inflammatory markers in the blood with different aspects of cancer treatment the survivors received. Investigators are investigating if there is a correlation between levels of these proteins and markers, the type of treatment cancer survivors received, and development of metabolic conditions.
Sites (1)
- Case Comprehensive Cancer Center, UH Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States